Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.13 +0.37 (+0.31%)
Official Closing Price Updated: 7:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
40 41 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Abbott Laboratories
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Abbott Laboratories Whale Trades For January 26
Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position... 
Via Benzinga
Abbott Labs Crushes Quarterly Views On Strong Covid Tests, But Shares Fall On Weak Outlook
Abbott reported $2.3 billion in Covid testing sales for the fourth quarter. 
Via Investor's Business Daily
Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook
Abbott Laboratories (NYSE: ABT) has reported Q4 FY21 adjusted EPS of $1.32, down from $1.45 a year ago but better than the consensus of $1.21. Q4 sales of $11.5... 
Via Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Recap: Abbott Laboratories Q4 Earnings
Abbott Laboratories (NYSE:ABT) reported its Q4 earnings results on Wednesday, January 26, 2022 at 07:30 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Gain; Fed Policy Decision In Focus
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of policy decision from the Federal Reserve. The Nasdaq index dropped by more than 300 points on... 
Via Benzinga
7 Stocks To Watch For January 26, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects AT&T Inc. (NYSE: T) to report quarterly earnings at $0.76 per share on revenue of $40.43... 
Via Benzinga
A Preview Of Abbott Laboratories's Earnings
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that... 
Via Talk Markets
Earnings Scheduled For January 26, 2022
Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter. • First BanCorp (NYSE:FBP) is likely to... 
Via Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the... 
Via Benzinga
Price Over Earnings Overview: Abbott Laboratories
Right now, Abbott Laboratories Inc. (NYSE:ABT) share price is at $126.19, after a 1.1% gain. Moreover, over the past month, the stock fell by 10.80%, but in the past... 
Via Benzinga
CNBC's Final Trades: Abbott Laboratories, Starbucks, Bank of America And This Financial Services Stock
On CNBC’s “Halftime Report... 
Via Benzinga
3 Dividend Aristocrats Yielding Over 4%
When looking for great dividend stocks, start with the Dividend Aristocrats. These companies have stood the test of time. 
Via InvestorPlace
3 Dividend Stocks to Buy and Hold Forever
Investors wanting dividends to fortify their portfolio should consider dividend stocks that deliver outsized payments to shareholders. 
Via InvestorPlace
Government Website For Free At-Home COVID Test Kit Opens Ahead Of Schedule: How To Get Yours
The U.S. government was set to officially open a website for Americans to order free COVID-19 rapid test kits on Wednesday, Jan. 19, but the site has begun taking names and... 
Via Benzinga
MLK Day Global News
In Q4 China's GDP growth rate halved to 4%. 
Via Talk Markets
AskSlim Market Week - Friday, Jan. 14
Technical and cycle analysis, and market commentary. 
Via Talk Markets
FDA Clears Abbott's Latest EnSite Heart Mapping Platform
Abbott Laboratories (NYSE: ABT) has scored clearance from the FDA for its latest 3D cardiac mapping platform, designed to help physicians target abnormal heart... 
Via Benzinga
Abbott Announces Future of Biowearables at Consumer Electronics Show
SOURCE: Abbott 
Via 3BL Media
Price Over Earnings Overview: Abbott Laboratories
In the current session, Abbott Laboratories Inc. (NYSE:ABT) is trading at $135.78, after a 0.4% gain. Over the past month, the stock increased by 2.13%, and in the... 
Via Benzinga
3 Top Stock Trades for the Week of Jan. 10, 2022
Sellers continue to push their advantage making it necessary to play defense to win. Here are three top stock trades for the new week. 
Via InvestorPlace
Wednesday Is Your Last Chance To Buy Abbott Laboratories Before The Dividend Payout
Wednesday marks the last chance for investors to receive the next dividend payout from Abbott Laboratories. What's Happening (N... 
Via Benzinga
This Company's Cardiac Monitor Has Caught the Eye of Johnson & Johnson and Stanford
Future Cardia’s device This post contains sponsored advertising content. The content that follows is for informational purposes only and not intended to be investing advice... 
Via Benzinga
How Digital Health Firms Like Apple, Alphabet And Garmin Are Innovating Far Beyond Your Wrist
Fitness trackers on display at CES 2022 are blazing a path toward a digital health future. 
Via Investor's Business Daily
Walmart And Kroger Jack Up Prices On COVID At-Home Tests After White House Agreement Not Extended
Walmart Inc. (NYSE: WMT) and The Kroger Company (NYSE: KR) have jacked up the price of the BinaxNOW rapid COVID-19 tests after a fixed-price sales deal with the Biden... 
Via Benzinga
6 Stocks Taking Center Stage At CES 2022, Including For The First Time A Healthcare Company
The Consumer Electronics Show (CES) in Las Vegas will be one of the most followed events of 2022 to kick off the year in the technology space. The show may come in... 
Via Benzinga
Best Stocks for 2022: Why AbbVie Looks Like High Dividend Growth Stock
A solid year and an excellent third-quarter report from AbbVie has ABBV stock look like it is one of the best stocks to buy for 2022. 
Via InvestorPlace
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.